Crescita Therapeutics (TSX:CTX) reported quarterly losses of $(0.06) per share. This is a 20 percent decrease over losses of $(0.05) per share from the same period last year. The company reported $5.637 million in sales this quarter. This is a 59.37 percent increase over sales of $3.537 million the same period last year.